2015 – 2018: PhD Scholarship Australian Postgraduate Award, AUD$26 682 pa. Thesis title: TGFβ, BMP and EGF interplay in the pathogenesis of fibrotic cataract: a tale of three growth factors
2015 – 2018: PhD Scholarship Sydney Eye Hospital Postgraduate Foundation Top-Up Scholarship, AUD$5000 pa
2016: Zhao G, Wazin F, Shu DY, Susanto A, Lovicu FJ. A role for the novel Spred proteins in regulating lens cell proliferation and differentiation. NWG Macintosh Memorial Grant, Discipline of Anatomy and Histology, University of Sydney, AUD$12 000 (Link)
2017: Shu DY, Das S, Lovicu FJ. Investigating the growth factor signalling pathways underlying the pathogenesis of human cataract. NWG Macintosh Memorial Grant, Discipline of Anatomy and Histology, University of Sydney, AUD$12 000 (Link)
2017: Shu DY, Das S, Lovicu FJ. How do cataracts form and how can we prevent them? Crowdfunding on www.experiment.com; DOI: 10.18258/9993, USD$2 630 (Link)
2019: Shu DY. Cancer Research Foundation Cell Imaging Grant for the EVOS M7000 Imaging System (AMF7000), USD$78, 315, Thermo Fisher Scientific (Link)
July 2020 – July 2021: Shu DY. Fight for Sight Leonard & Robert Weintraub Postdoctoral Fellowship, USD$22, 500. Fight for Sight United States (Link)
July 2021 – July 2023: Shu DY. Postdoctoral Fellowship Program in Macular Degeneration Research, USD$200, 000. BrightFocus Foundation, M2021010F (Link)
2022-2022: Shu DY. Interstellar Initiative by the Japan Agency for Medical Research and Development (AMED) and the New York Academy of Sciences. The initiative aims to increase international and interdisciplinary collaboration uniting scientists within the early stages of their careers and catalyzing scientific advancement 2700000JPY (18598USD). nyas.org/interstellar
2023-2026: Kim LA & Shu DY. The Role of the Rho-Kinase Pathway in Proliferative Vitreoretinopathy. Department of Defence Congressionally Directed Medical Research Programs Vision Research Program Investigator-Initiated Research Award ($500K USD)
2023-2027: Shu DY. UNSW Scientia Program, Salary support and AUD$50,000 pa in research support. This is a highly competitive program supporting outstanding early- to mid-career researchers to establish independent research programs.
2024-2025: Shu DY (CIA), Ksander B (Harvard), Mackey D (UWA), Wong R (CERA), Hewitt A (UTas), Enhancing mitochondrial function through epigenetic reprogramming in a stem-cell model of Leber’s Hereditary Optic Neuropathy (LHON), Mito Foundation Incubator Grant, AUD$25,000 over 1 year.
2024: Shu DY (CIA), A Laser Photocoagulation System for Precision Modelling Retinal and Ocular Pathologies, UNSW Research Infrastructure Scheme (RIS), AUD$104,225.
2024: Luque Daniel (CIA), Shu DY (Co-CI), New rotors to expand ultracentrifuge capabilities in biomedical research, UNSW Research Infrastructure Scheme (RIS), AUD$179,830.
2025: Shu DY (CIA), Madigan MC, Misra A, Colchicine as a novel therapeutic for treating vascular abnormalities in Type 2 Diabetic Retinopathy, SOVS Diabetes Research Grant from the Elizabeth O’Beirne and Robert and Emmy Mather Trust Fund, AUD$20,000.
2025-2028: Shu DY (CIA), Wich P, Willcox M, Liu Guei-Sheung (Rick), From Fumarates to Microtubules: novel anti-angiogenic and anti-fibrotic therapies for AMD, BrightFocus Foundation New Investigator Grant in Macular Degeneration Research, USD$405,000 over 3 years. Grant number: M2025005N
2026: Shu DY (Co-CIA) & Yam A (Co-CIA), Chtanova T, Shivdasani M, Di Girolamo N, A SMARTIE Approach to Retinal Angiogenesis: Seeing Immune Cells in Colour. UNSW Triple I Collaboration Grant. AUD$25,000 over 1 year.
Key Personnel on Grants
November 2021: You Jingjing. Global Development Awards, Office of Global Engagement (OGE) at the University of Sydney, Australia. The Global Development Awards include a structured training program, mentoring and where required, teaching relief, to provide focused time for international research development (Link) AUD$25, 000